Skip to Main Content

Author Details

Lawson Eng
Princess Margaret Cancer Centre, University Health Network, University of Toronto
2011
58
17
PMIDPaper TitleJournal TitlePublished Year
36416855Association of Household Income at Diagnosis With Financial Toxicity, Health Utility, and Survival in Patients With Head and Neck Cancer.JAMA Otolaryngol Head Neck Surg2023
38063318First impressions: A prospective evaluation of patient-physician concordance and satisfaction following the initial medical oncology consultation.Cancer Med2023
37611213Reply to F. Poizeau et al.J Clin Oncol2023
37979334Presentation and outcomes of KRAS<sup>G12C</sup> mutant non-small cell lung cancer patients with stage IV disease at diagnosis (de novo) versus at recurrence.Cancer Treat Res Commun2023
37498564Individualized risk assessment of distant metastases in oral cavity carcinoma: a validated predictive-score model.J Natl Cancer Inst2023
36688707Use of artificial intelligence for cancer clinical trial enrollment: a systematic review and meta-analysis.J Natl Cancer Inst2023
36827626Impact of Antibiotic Exposure Before Immune Checkpoint Inhibitor Treatment on Overall Survival in Older Adults With Cancer: A Population-Based Study.J Clin Oncol2023
34428351Out-of-pocket costs associated with head and neck cancer treatment.Cancer Rep (Hoboken)2022
35588085Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort.Cancer2022
36173560Exercise counselling and referral in cancer care: an international scoping survey of health care practitioners' knowledge, practices, barriers, and facilitators.Support Care Cancer2022
36135061Tobacco Use and Response to Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer.Curr Oncol2022
36356412Reporting of tobacco use and tobacco-related analyses in cancer cooperative group clinical trials: a systematic scoping review.ESMO Open2022
36215684Understanding the Role of Cannabis in Cancer Care: An Emerging Priority.JCO Oncol Pract2022
34524527The use of patient-reported outcomes in routine cancer care: preliminary insights from a multinational scoping survey of oncology practitioners.Support Care Cancer2022
33290162Increasing Referrals of Patients With Gastrointestinal Cancer to a Cancer Rehabilitation Program: A Quality Improvement Initiative.JCO Oncol Pract2021
33651181Internet and social media use in cancer patients: association with distress and perceived benefits and limitations.Support Care Cancer2021
33582072Systemic Inflammatory Markers of Survival in Epidermal Growth Factor-Mutated Non-Small-Cell Lung Cancer: Single-Institution Analysis, Systematic Review, and Meta-analysis.Clin Lung Cancer2021
34509615The efficacy, challenges, and facilitators of telemedicine in post-treatment cancer survivorship care: an overview of systematic reviews.Ann Oncol2021
33956861Advancing health equity in cancer care: The lived experiences of poverty and access to lung cancer screening.PLoS One2021
31119706Investigating the Smoking Cessation Informational Needs of Cancer Patients and Informal Caregivers.J Cancer Educ2020
32029357Smoking Cessation in Cancer Care: Myths, Presumptions and Implications for Practice.Clin Oncol (R Coll Radiol)2020
32104096Cancer Patient-Reported Preferences and Knowledge for Liquid Biopsies and Blood Biomarkers at a Comprehensive Cancer Center.Cancer Manag Res2020
31974768Health-related social media use and preferences of adolescent and young adult cancer patients for virtual programming.Support Care Cancer2020
32603521Measuring financial toxicity incurred after treatment of head and neck cancer: Development and validation of the Financial Index of Toxicity questionnaire.Cancer2020
32857771Nicotine dependence as a risk factor for upper aerodigestive tract (UADT) cancers: A mediation analysis.PLoS One2020
30324631Patterns, perceptions and their association with changes in alcohol consumption in cancer survivors.Eur J Cancer Care (Engl)2019
31896943Combined cancer patient-reported symptom and health utility tool for routine clinical implementation: a real-world comparison of the ESAS and EQ-5D in multiple cancer sites.Curr Oncol2019
31896934Implementation of a comprehensive smoking cessation program in cancer care.Curr Oncol2019
31650705Real-world health utility scores and toxicities to tyrosine kinase inhibitors in epidermal growth factor receptor mutated advanced non-small cell lung cancer.Cancer Med2019
29982902Development and prospective evaluation of CAPLET, a cancer ambulatory patient physical function longitudinal evaluation tool for routine clinical practice.Support Care Cancer2019
31355511Association of two BRM promoter polymorphisms and smoking status with malignant pleural mesothelioma risk and prognosis.Mol Carcinog2019
31409744Acceptability of Routine Evaluations Using Patient-Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient-Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience.Oncologist2019
30897287Impact of immigration status on health behaviors and perceptions in cancer survivors.Cancer Med2019
30964445Implementation of a Novel Electronic Patient-Directed Smoking Cessation Platform for Cancer Patients: Interrupted Time Series Analysis.J Med Internet Res2019
27075196Preferences for the Provision of Smoking Cessation Education Among Cancer Patients.J Cancer Educ2018
32700029Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).Oncol Ther2018
29808379Patterns, perceptions, and perceived barriers to physical activity in adult cancer survivors.Support Care Cancer2018
29905764Health utility scores from EQ-5D and health-related quality of life in patients with esophageal cancer: a real-world cross-sectional study.Dis Esophagus2018
29676948Perceptions of Continued Smoking and Smoking Cessation Among Patients With Cancer.J Oncol Pract2018
27567613EQ-5D Health Utility Scores: Data from a Comprehensive Canadian Cancer Centre.Patient2017
28088657Early adulthood body mass index, cumulative smoking, and esophageal adenocarcinoma survival.Cancer Epidemiol2017
28111120Real-World EQ5D Health Utility Scores for Patients With Metastatic Lung Cancer by Molecular Alteration and Response to Therapy.Clin Lung Cancer2017
28427211Association of BRM promoter polymorphisms and esophageal adenocarcinoma outcome.Oncotarget2017
28074552Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survival.Cancer Med2017
28050143Socioeconomic status and lifestyle behaviours in cancer survivors: smoking and physical activity.Curr Oncol2016
25156642Negotiating learner-teacher boundaries in medical education.Med Teach2015
26060227Lifestyle Behaviors in Elderly Cancer Survivors: A Comparison With Middle-Age Cancer Survivors.J Oncol Pract2015
25826681Appropriateness of using patient-derived xenograft models for pharmacologic evaluation of novel therapies for esophageal/gastro-esophageal junction cancers.PLoS One2015
25877384The role of second-hand smoke exposure on smoking cessation in non-tobacco-related cancers.Cancer2015
26014353Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome.Carcinogenesis2015
  • 1 - 50 of 58

Recommended Authors

Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 0
University of Cincinnati
Career Start Year 2016
Number of shared co-authors 1
Winship Cancer Institute of Emory University
Career Start Year 2015
Number of shared co-authors 5
Memorial Sloan Kettering Cancer Center
Career Start Year 2015
Number of shared co-authors 2
Princess Margaret Cancer Centre, University of Toronto
Career Start Year 2013
Number of shared co-authors 10
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Career Start Year 2012
Number of shared co-authors 2
Oncology Center of Excellence
Career Start Year 2012
Number of shared co-authors 0
San Diego State University School of Public Health
Career Start Year 2011
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Cross Cancer Institute
Career Start Year 2006
Number of shared co-authors 1
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 0
The Ottawa Hospital Research Institute
Career Start Year 2005
Number of shared co-authors 11
Yonsei Cancer Center, Yonsei University College of Medicine
Career Start Year 2005
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 2003
Number of shared co-authors 2
Marti Nelson Cancer Foundation
Career Start Year 2003
Number of shared co-authors 1
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year 2001
Number of shared co-authors 17
Cancer Center Amsterdam
Career Start Year 2001
Number of shared co-authors 5
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 0
UF Health Cancer Center
Career Start Year 1998
Number of shared co-authors 1
City of Hope Comprehensive Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 3
Mayo Clinic
Career Start Year 1996
Number of shared co-authors 6
Odette Cancer Centre
Career Start Year 1996
Number of shared co-authors 3
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 1
Memorial-Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 3
University of British Columbia
Career Start Year 1995
Number of shared co-authors 6
Mayo Clinic
Career Start Year 1994
Number of shared co-authors 1
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 1
University of California irvine
Career Start Year 1988
Number of shared co-authors 3
University of Alabama at Birmingham
Career Start Year 1979
Number of shared co-authors 0

Collaborators

The Princess Margaret Cancer Centre/University of Toronto
Co-authored papers 42
Princess Margaret Cancer Centre
Co-authored papers 34
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 13
SLR Consulting (Canada) Ltd
Co-authored papers 8
University of Toronto
Co-authored papers 6
University Health Network, Princess Margaret Cancer Centre
Co-authored papers 5
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
McMaster University
Co-authored papers 5
The First Hospital of Lanzhou University
Co-authored papers 5
Memorial University
Co-authored papers 4
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 4
University of Dhaka
Co-authored papers 4
University Health Network
Co-authored papers 4
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 4
Princess Margaret Cancer Centre
Co-authored papers 3
Qingpu Branch of Zhongshan Hospital, Fudan University
Co-authored papers 3
Princess Margaret Cancer Centre
Co-authored papers 3
University of Toronto
Co-authored papers 3
Princess Margaret Cancer Center
Co-authored papers 3
Princess Margaret Cancer Centre
Co-authored papers 3
University of Toronto
Co-authored papers 3
Zhabei Central Hospital
Co-authored papers 2
Princess Margaret Cancer Centre
Co-authored papers 2
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 1
University of Toronto
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
Toronto General Hospital
Co-authored papers 1
Toronto General Research Institute, University Health Network
Co-authored papers 1
University Health Network, University of Toronto
Co-authored papers 1